• Northwest Biotherapeutics Acquires Flaskworks americanpharmaceuticalreview
    September 03, 2020
    Northwest Biotherapeutics announced the Company has acquired Flaskworks, a company that has developed a system to close and automate the manufacturing of cell therapy products such as DCVax®.
PharmaSources Customer Service